Zytoprotec Competitors and Similar CompaniesClear all

Zytoprotec's competitors and similar companies include OriGene Technologies, BioCryst Pharmaceuticals and Bioiberica.

	Zytoprotec Zytoprotec is a life science company that develops drugs using a cytoprotection therapeutic approach.	OriGene Technologies OriGene Technologies is a company specializing in biotechnology research.	BioCryst Pharmaceuticals BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that block key enzymes to treat rare diseases.	Bioiberica Bioiberica is a life science company engaged in the identification, extraction, and development of animal-derived biomolecules.
Founding Date	Founding Date 2007	Founding Date 1996	Founding Date 1986	Founding Date 1975
Type	Type Private	Type Subsidiary	Type Public	Type Subsidiary
Tags	Tags Healthcare biotech drug development life sciences pharma	Tags Healthcare biotech life sciences pharma	Tags Healthcare biotech drug development life sciences pharma	Tags Healthcare biotech drug development life sciences pharma
Locations	Locations Wien, AT HQ	Locations Rockville, US HQ Herford, DE Newark, US Windham, US	Locations Durham, US HQ Hoover, US	Locations Esplugues de Llobregat, ES HQ Barcelona, ES Palafolls, ES
Employees	Employees N/A	Employees 1242% increase	Employees 14040% increase	Employees 332
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $874.8m (FY, 2025)	Revenue (est.) $346.7m (FY, 2018)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $19.1m (FY, 2025)	Cost of goods $190.3m (FY, 2018)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $855.8m (FY, 2025)	Gross profit $156.4m (FY, 2018)
Net income	Net income N/A	Net income N/A	Net income $263.9m (FY, 2025)	Net income $40.5m (FY, 2018)
Funding
Total funding raised	Total funding raised $ 2.7m	Total funding raised $ 69.6m	Total funding raised $ 1.9m	Total funding raised N/A